StonvexLoading…
StonvexCore line items from PKG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $8.99B | $8.38B | $7.80B | $8.48B |
Operating Income | $1.11B | $1.10B | $1.08B | $1.42B |
Net Income | $774.10M | $805.10M | $765.20M | $1.03B |
EPS (Diluted) | $8.58 | $8.93 | $8.48 | $11.03 |
Total Assets | $10.73B | $8.83B | $8.68B | $8.00B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $529.00M | $685.00M | $648.00M | $320.00M |
Free Cash Flow OCF − CapEx | $728.60M | $521.50M | $845.40M | $670.80M |
Shares Outstanding | 89.60M | 89.50M | 89.50M | 92.70M |